Medicines Classification Committee

The industry body representing medicines manufacturers is concerned a lack of clarity around the upcoming codeine-containing medicines reclassification may result in a situation like the recent dextromethorphan-containing medicines “shambles”

When Gees Linctus and dextromethorphan-containing medicines were reclassified on 25 February, no one heard about it

Last week’s surprise change to cough medicine classifications will result in more than 200,000 products being recalled and cost manufacturers hundreds of thousands of dollars, a pharmaceutical industry body says.

Community pharmacists who become suitably certified will be able to dispense the cancer treatment drug thalidomide from next month.

No change has been made to the classification of codeine, but the Medicines Classification Committee (MCC) has posed some questions to the sector that it must answer if some codeine products are to remain pharmacist-only.